There is growing evidence that ALKBH5 is an essential regulator of tumor progression and is involved in the malignant progression of several tumor types,24 including breast cancer,25 GBM,26 and acute myeloid leukemia,27 by demethylating m6A‐modified mRNA. This evidence concerns the gene ALKBH5 and glioblastoma.